Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
08/28/2013 | CN102512514B Normal-temperature preparation method for ultrafine coccidia powder and special bilateral airflow sieving machine thereof |
08/28/2013 | CN102512452B Process method for preparing sea cucumber glycosides by using sea cucumber coelomic fluid |
08/28/2013 | CN102477073B Oligopeptide with thrombolytic activity, preparation method thereof, and application thereof |
08/28/2013 | CN102406749B HPLC (high-performance liquid chromatography) detection method capable of simultaneously detecting contents of six amino acids in donkey-hide glue blood-supplementing preparation |
08/28/2013 | CN102277330B Human CD3+CD8+gamma delta T lymphocyte, as well as preparation method and application thereof |
08/28/2013 | CN102258679B Traditional Chinese medicine composition and preparation method and application thereof |
08/28/2013 | CN102204951B Method for extracting active components from licorice |
08/28/2013 | CN102120727B N-[(3S)-N-aminoacyl-1,2,3,4-tetrahydroisoquinoline-3-formacyl]amino acid and synthesis method and application thereof |
08/28/2013 | CN101981035B Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments |
08/28/2013 | CN101981006B Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
08/27/2013 | US8519111 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
08/27/2013 | US8519103 Factor VII polypeptides that are modified and uses thereof |
08/27/2013 | US8518999 Modulators of TNF-αsignaling |
08/27/2013 | US8518997 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
08/27/2013 | US8518977 Benzamides and related inhibitors of factor XA |
08/27/2013 | US8518909 Sulfated heptasaccharide and its use as an antithrombotic agent |
08/27/2013 | US8518896 Treatment of cancers of the blood using selected glycomimetic compounds |
08/27/2013 | US8517967 Methods of using an apparatus for prolonging survival of platelets using CMP-sialic acid, UDP-galactose or both |
08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
08/22/2013 | WO2013123248A1 MODULATION OF FACTOR Xa INHIBITOR MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE |
08/22/2013 | WO2013122855A1 Methods of increasing lymphatic transport |
08/22/2013 | WO2013121416A1 Long-acting coagulation factors and methods of producing same |
08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
08/21/2013 | EP2628733A1 Acylbenzene derivative |
08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
08/21/2013 | CN103261209A Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
08/21/2013 | CN103261161A Crystalline forms of a factor Xa inhibitor |
08/21/2013 | CN103260649A Long lasting drug formulations |
08/21/2013 | CN103260633A Hemostatic preparation containing an extract of golden moss |
08/21/2013 | CN103260628A Use of hyaluronan for promoting angiogenesis |
08/21/2013 | CN103255042A Sea cucumber health-care wine and brewing method thereof |
08/21/2013 | CN103255021A Health preserving wine |
08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
08/21/2013 | CN103254155A Tetrahydropyrrole derivative and preparation method thereof |
08/21/2013 | CN103251954A Diabetes treating compound medicine for reducing side effect of rosiglitazone and preparation method thereof |
08/21/2013 | CN103251953A Flt3 inhibitors for immune suppression |
08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
08/21/2013 | CN103251936A Oxygen carrier based on hemoglobin-haptoglobin compound and preparation method of oxygen carrier |
08/21/2013 | CN103251897A Traditional Chinese medicine powder for eliminating swelling and preparation method thereof |
08/21/2013 | CN103251886A Chinese medicine for treating postpartum lochiorrhea and preparation method thereof |
08/21/2013 | CN103251856A Traditional Chinese medicine preparation for benefiting Qi and nourishing blood and preparation method of traditional Chinese medicine preparation |
08/21/2013 | CN103251777A Application of aloe |
08/21/2013 | CN103251764A Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
08/21/2013 | CN103251730A Granules for treating upper gastrointestinal hemorrhage and ulcer and preparation method thereof |
08/21/2013 | CN103251648A Iron-based montmorillonite medicine for treating hyperphosphatemia and iron-deficiency anemia and preparation method of iron-based montmorillonite medicine |
08/21/2013 | CN103251647A Methods for treating bleeding disorders using sulfated polysaccharides |
08/21/2013 | CN103251646A Application of rutabaga polysaccharide |
08/21/2013 | CN103251627A Application of carbenoxolone or salt thereof in preparation of medicine for treating inflammatory diseases |
08/21/2013 | CN103251610A Application of Aspeverin in preparation of anti-platelet aggregation medicines |
08/21/2013 | CN103251580A Application of ampelopsin in preparation of vascular endothelial cell protection health food or drugs |
08/21/2013 | CN103251575A Application of paeonol in preparing anti-endotoxemia drug |
08/21/2013 | CN103251564A Azacitidine for injection and preparation method thereof |
08/21/2013 | CN103250878A Traditional Chinese medicine feed for treating swine plague, as well as preparation method and appliction thereof |
08/21/2013 | CN103006999B Pill for preventing, curing and nursing renal calculi |
08/21/2013 | CN102698087B Medicament for treating acute gastrorrhagia and preparation method of medicament |
08/21/2013 | CN102526129B Method for preparing Poria cocos granules by replacing part of auxiliary materials with ultrafine powder |
08/21/2013 | CN102512520B Normal-temperature preparation method for ultrafine powder hawthorn |
08/21/2013 | CN102362929B Chinese medicinal composition and extract for treating cancer ischemia, and preparation method and formulation of Chinese medicinal extract |
08/21/2013 | CN102327401B Method for preparing medicament for treating uterine bleeding |
08/21/2013 | CN102302709B Preparation method for medicament for treating pediatric disease |
08/21/2013 | CN102293873B Preparation method of Bazheng mixture |
08/21/2013 | CN102274493B Bleeding-stopping, inflammation-diminishing and pain-relieving nano emulsion for use in minimally invasive beauty treatment therapy and preparation method thereof |
08/21/2013 | CN102198148B Compound malic acid Ringer's solution and application thereof |
08/21/2013 | CN102183665B Method and apparatus for monitoring anti-platelet agents |
08/21/2013 | CN102171329B Lactic acid bacterium having high oxalic acid decomposition ability |
08/21/2013 | CN101802188B Antidotes for factor xa inhibitors and methods of using the same |
08/21/2013 | CN101743244B Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
08/21/2013 | CN101631785B Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
08/21/2013 | CN101555274B Preparation method of polypeptide solid-phase synthesis bivalirudin crude product |
08/20/2013 | US8513189 Albumin fusion proteins |
08/20/2013 | US8512994 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
08/20/2013 | US8512993 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
08/20/2013 | US8512969 Methods for analyzing a heparin sample |
08/20/2013 | US8512740 Fibrin foam and process for making |
08/20/2013 | US8512718 Pharmaceutical composition for topical application |
08/20/2013 | CA2804129C Manufacturing method for dried earthworm powder |
08/20/2013 | CA2587924C Oral compositions for absorption of phosphorus compounds |
08/20/2013 | CA2557061C Factor ixa for the treatment of bleeding disorders |
08/20/2013 | CA2488558C Prevention and reduction of blood loss |
08/20/2013 | CA2445349C Anti-cd40 monoclonal antibody |
08/15/2013 | WO2013119870A1 Compositions and methods for treatment of peripheral vascular disease |
08/15/2013 | WO2013064703A3 Fkbp subtype-specific rapamycin analogue for use in treatment of diseases |
08/15/2013 | US20130210136 Methods For Treating Cardio Pulmonary Diseases With NO Group Compounds |
08/15/2013 | US20130209441 Process for inhibition of cerebral damage associated with ischemia by anthocyanins and anthocyanidins |
08/14/2013 | EP2626080A2 Conjugated factor VIII molecules |
08/14/2013 | EP2626079A2 Conjungated factor VIII molecules |
08/14/2013 | EP2626074A1 Methods and compositions for administration of iron |
08/14/2013 | EP2626071A1 Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction |
08/14/2013 | EP2626069A1 Prophylactic and/or therapeutic agent against lymphedema |
08/14/2013 | EP2624859A1 Factor ii and fibrinogen for treatment of haemostatic disorders |
08/14/2013 | EP2624852A1 Diagnostic and therapeutic uses of moesin fragments |
08/14/2013 | EP2624842A2 Use of hyaluronan for promoting angiogenesis |
08/14/2013 | CN103249726A Acylbenzene derivative |
08/14/2013 | CN103242444A Modulation of SIRP-alpha - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
08/14/2013 | CN103242417A Sterol derivative, and preparation method and application thereof |
08/14/2013 | CN103242367A 2-aryloxy-3-aryl-3,4-dihydro-2H-1,3,2-benzo-phosphoramidate compound with insecticidal activity and applications thereof |
08/14/2013 | CN103242337A Ginkgolide B derivative based on double target spots of PAF (Platelet Activating Factor)/ROS (Reactive Oxygen Species), and preparation method of derivative |
08/14/2013 | CN103242310A Pyrazolo pyridone compound and its application in preparation of anticoagulant |
08/14/2013 | CN103242307A Crystal form I of oxazolidinone derivative as well as preparation method and application of crystal form I |
08/14/2013 | CN103242296A Dabigatran etexilate analogue with fluorine-containing group modified pyridine ring as center and synthesis method of analogue |